• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌肉特异性激酶(MuSK)阳性重症肌无力患者的生活质量

Quality of life in patients with MuSK positive myasthenia gravis.

作者信息

Stankovic Milica, Peric Stojan, Stojiljkovic Tamas Olivera, Stankovic Tamara, Nikolic Ana, Lavrnic Dragana, Basta Ivana

机构信息

School of Medicine, University of Belgrade, Belgrade, Serbia.

School of Medicine, Neurology Clinic, Clinical Centre of Serbia, University of Belgrade, Dr Subotica Starijeg 6, 11 000, Belgrade, Serbia.

出版信息

Acta Neurol Belg. 2018 Sep;118(3):423-427. doi: 10.1007/s13760-018-0915-y. Epub 2018 Mar 28.

DOI:10.1007/s13760-018-0915-y
PMID:29594965
Abstract

It is believed that myasthenia gravis (MG) with antibodies to muscle-specific tyrosine kinase (MuSK) is the most severe form of the disease, especially in the first years of the disease. The aim of our study was to investigate quality of life (QoL) in a population of patients with MuSK MG compared to those with MG who have antibodies to acetylcholine receptor (AChR) in their sera. The study group consisted of 35 MuSK MG patients (28 females and 7 males), while the control group included 38 AChR MG patients matched for gender, age, and duration of the disease. SF-36 questionnaire was used to evaluate the health-related QoL. Following scales were also used: Hamilton's scales for depression and anxiety, the Multidimensional Scale of Perceived Social Support, and the Acceptance of Illness Scale. Physical domain scores of QoL were similarly affected in both MuSK and AChR groups, while mental domain and total SF-36 scores were even better in MuSK MG patients. Social support was better in the MuSK group (77.3 ± 9.3 vs. 70.6 ± 14.1, p < 0.05). SF-36 total score correlated with depression (rho = 0.54, p < 0.01), anxiety (rho = 0.49, p < 0.01), and MSPSS (rho = - 0.35, p < 0.05), and depression was an independent predictor of worse QoL. Besides therapy of weakness, psychiatric treatment and different forms of psychosocial condition should be part of regular therapeutic protocols for MG. Adequate team work of health professionals and family can provide a healthy mental environment in which a MuSK MG patient would feel more comfortable in spite of the disease.

摘要

据信,伴有肌肉特异性酪氨酸激酶(MuSK)抗体的重症肌无力(MG)是该病最严重的形式,尤其是在疾病的最初几年。我们研究的目的是调查与血清中含有抗乙酰胆碱受体(AChR)抗体的MG患者相比,MuSK MG患者群体的生活质量(QoL)。研究组由35例MuSK MG患者(28名女性和7名男性)组成,而对照组包括38例在性别、年龄和病程方面匹配的AChR MG患者。使用SF-36问卷评估与健康相关的生活质量。还使用了以下量表:汉密尔顿抑郁和焦虑量表、多维感知社会支持量表以及疾病接受量表。MuSK组和AChR组的生活质量身体领域得分受到类似影响,而MuSK MG患者的心理领域和SF-36总分甚至更好。MuSK组的社会支持更好(77.3±9.3对70.6±14.1,p<0.05)。SF-36总分与抑郁(rho = 0.54,p<0.01)、焦虑(rho = 0.49,p<0.01)和MSPSS(rho = -0.35,p<0.05)相关,抑郁是生活质量较差的独立预测因素。除了肌无力治疗外,心理治疗和不同形式的心理社会状况应成为MG常规治疗方案的一部分。健康专业人员和家庭的充分团队合作可以提供一个健康的心理环境,使MuSK MG患者尽管患病仍会感觉更舒适。

相似文献

1
Quality of life in patients with MuSK positive myasthenia gravis.肌肉特异性激酶(MuSK)阳性重症肌无力患者的生活质量
Acta Neurol Belg. 2018 Sep;118(3):423-427. doi: 10.1007/s13760-018-0915-y. Epub 2018 Mar 28.
2
MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.MuSK抗体相关重症肌无力面部及延髓肌受累的MRI与临床研究
Brain. 2006 Jun;129(Pt 6):1481-92. doi: 10.1093/brain/awl095. Epub 2006 May 3.
3
Myasthenia gravis experimentally induced with muscle-specific kinase.用肌肉特异性激酶实验性诱导的重症肌无力
Ann N Y Acad Sci. 2008;1132:93-8. doi: 10.1196/annals.1405.002. Epub 2007 Dec 20.
4
Antibody profile may predict outcome in ocular myasthenia gravis.抗体谱可能预测眼肌型重症肌无力的预后。
Acta Neurol Belg. 2018 Sep;118(3):435-443. doi: 10.1007/s13760-018-0943-7. Epub 2018 Jun 1.
5
Muscle-Specific Receptor Tyrosine Kinase (MuSK) Myasthenia Gravis.肌肉特异性受体酪氨酸激酶(MuSK)重症肌无力。
Curr Neurol Neurosci Rep. 2016 Jul;16(7):61. doi: 10.1007/s11910-016-0668-z.
6
Myopathy, muscle atrophy and tongue lipid composition in MuSK myasthenia gravis.MuSK重症肌无力中的肌病、肌肉萎缩和舌脂成分
Acta Neurol Belg. 2015 Sep;115(3):361-5. doi: 10.1007/s13760-014-0364-1. Epub 2014 Sep 25.
7
Maintenance plasma exchange treatment for muscle specific kinase antibody positive myasthenia gravis patients.肌肉特异性激酶抗体阳性重症肌无力患者的维持性血浆置换治疗
J Clin Apher. 2015 Oct;30(5):314-9. doi: 10.1002/jca.21377. Epub 2014 Dec 30.
8
Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.无乙酰胆碱受体抗体的重症肌无力患者中针对受体酪氨酸激酶MuSK的自身抗体。
Nat Med. 2001 Mar;7(3):365-8. doi: 10.1038/85520.
9
Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.抗肌肉特异性激酶(MuSK)患者抗体破坏小鼠神经肌肉接头。
Ann Neurol. 2008 Jun;63(6):782-9. doi: 10.1002/ana.21371.
10
Clinical and scientific aspects of muscle-specific tyrosine kinase-related myasthenia gravis.肌肉特异性酪氨酸激酶相关重症肌无力的临床与科学方面
Curr Opin Neurol. 2014 Oct;27(5):558-65. doi: 10.1097/WCO.0000000000000136.

引用本文的文献

1
MuSK Myasthenia Gravis-Potential Pathomechanisms and Treatment Directed against Specific Targets.抗 MuSK 型重症肌无力-潜在的发病机制和针对特定靶点的治疗方法。
Cells. 2024 Mar 21;13(6):556. doi: 10.3390/cells13060556.
2
Systematic review of the patient burden of generalised myasthenia gravis in Europe, the Middle East, and Africa.欧洲、中东和非洲重症肌无力患者负担的系统评价。
BMC Neurol. 2024 Feb 10;24(1):61. doi: 10.1186/s12883-024-03553-y.
3
Prevalence of depression among Iranian patients with myasthenia gravis during 2017-2018.
2017 - 2018年伊朗重症肌无力患者中抑郁症的患病率。
Curr J Neurol. 2020 Oct 6;19(4):162-166. doi: 10.18502/cjn.v19i4.5542.
4
Health-related quality of life (HRQoL) and psychological impact of the COVID-19 pandemic on patients with myasthenia gravis.2019年冠状病毒病大流行对重症肌无力患者与健康相关的生活质量及心理影响
Intractable Rare Dis Res. 2023 May;12(2):88-96. doi: 10.5582/irdr.2023.01003.
5
COVID-19 infection and vaccination against SARS-CoV-2 in myasthenia gravis.COVID-19 感染和 SARS-CoV-2 疫苗接种在重症肌无力中的作用。
Acta Neurol Belg. 2023 Apr;123(2):529-536. doi: 10.1007/s13760-022-02121-w. Epub 2022 Oct 24.
6
Anti-titin antibody is associated with more frequent hospitalization to manage thymoma-associated myasthenia gravis.抗肌联蛋白抗体与更频繁住院治疗胸腺瘤相关重症肌无力有关。
Front Neurol. 2022 Oct 5;13:978997. doi: 10.3389/fneur.2022.978997. eCollection 2022.
7
Factors associated with quality of life of people with Myasthenia Gravis.与重症肌无力患者生活质量相关的因素。
PLoS One. 2018 Nov 8;13(11):e0206754. doi: 10.1371/journal.pone.0206754. eCollection 2018.